Roche, Exelixis suffer another late-stage cancer combo failure
FDA has new leverage over companies looking for a quicker drug approval
FDA rejected human trial for Elon Musk's brain chip tech
Spotlight on what's next in NASH
*please scroll down for all the latest news*
